AMRI’s Global Analytical Services has launched a new forced degradation service to meet the industry demand for supporting drug substance, product including medical devices, and associated packaging system development and commercialization. “We are excited to introduce this service to help our customers navigate the lack of specific regulatory recommendations in available guidance documents on how to conduct forced degradation studies,” said Pamela Smith, vice president, global analytical ser...